 PALO ALTO, Calif., Aug. 31, 2021 PRNewswire -- Kodiak Sciences Inc. Nasdaq: KOD, a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the virtual Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021, at 8:45 a.m. 